Literature DB >> 4032540

Sexual function and female radical cystectomy: a case series.

L R Schover, A C von Eschenbach.   

Abstract

We interviewed 9 sexually active women about sexual function before and after radical cystectomy. Of the women 6 also had received preoperative irradiation. Seven women resumed sexual activity. All subjects experienced dyspareunia on initial attempts but 6 had overcome the pain at followup 6 to 37 months postoperatively. These women were coitally orgasmic and reported no decrease in pleasure or change in the type of sexual stimulation required to produce orgasm. The results provide knowledge about the physiology of female orgasm and a basis for counseling patients.

Entities:  

Mesh:

Year:  1985        PMID: 4032540     DOI: 10.1016/s0022-5347(17)47242-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  [Quality of life after radical urologic pelvic surgery and impact of inpatient rehabilitation].

Authors:  O Dombo; U Otto
Journal:  Urologe A       Date:  2005-01       Impact factor: 0.639

2.  Sexual function after partial cystectomy and urothelial stripping in a 32-year-old woman with radiation cystitis.

Authors:  Hendrik W Elzevier; Katja N Gaarenstroom; August A B Lycklama á Nijeholt
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-01-13

Review 3.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

4.  Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence.

Authors:  Agustina Bessa; Rebecca Martin; Christel Häggström; Deborah Enting; Suzanne Amery; Muhammad Shamim Khan; Fidelma Cahill; Harriet Wylie; Samantha Broadhead; Kathryn Chatterton; Sachin Malde; Rajesh Nair; Ramesh Thurairaja; Pardeep Kumar; Anna Haire; Saran Green; Margaret Northover; Karen Briggs; Mieke Van Hemelrijck
Journal:  BMC Urol       Date:  2020-06-03       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.